|
|
News for Healthier Living
FDA Clears Blood Test to Aid Evaluation for Alzheimer's Disease
The FDA has cleared a blood test developed from technology invented at WashU Medicine to aid in diagnosing Alzheimer's disease. The test, PrecivityAD2, can detect amyloid plaque biomarkers with over 90% accuracy, offering a less invasive alternative to spinal taps and brain scans.
August 21, 2026
September 1 2026August 31 2026August 30 2026August 29 2026August 28 2026August 27 2026August 26 2026August 25 2026August 24 2026August 21 2026August 20 2026August 19 2026August 18 2026
|
|
|
|
|